Open Access
Open access
Cancer Science, volume 109, issue 8, pages 2391-2400

Resistin facilitates metastasis of lung adenocarcinoma through the TLR 4/Src/ EGFR / PI 3K/ NF ‐κB pathway

Wei-Jing Gong 1, 2
Jun-Yan Liu 3
Jiajia Cui 1
Di Xiao 4
Wei Zhuo 1
Chao Luo 1
Rui Jie Liu 5
Xi Li 1
Wei Zhang 1
Hong-Hao Zhou 1
Show full list: 11 authors
Publication typeJournal Article
Publication date2018-07-20
Journal: Cancer Science
scimago Q1
SJR1.625
CiteScore9.9
Impact factor4.5
ISSN13479032, 13497006
PubMed ID:  29927028
Cancer Research
Oncology
General Medicine
Abstract
Metastasis is the main cause of lung cancer-related death. The tumor microenvironment greatly contributes to tumor metastasis. Resistin, mainly secreted by tumor-associated macrophages in tumor tissues, is a 12.5-kDa cysteine-rich secretory protein that is found at significantly higher levels in the serum or plasma of cancer patients compared with healthy controls. In this study, we explored the expression and role of resistin in lung adenocarcinoma. Our study showed that resistin was strongly expressed in lung adenocarcinoma tissues and promoted the migration and invasion of lung adenocarcinoma cells in a dose-dependent manner. Toll-like receptor 4 (TLR4) was the functional receptor of resistin for migration and invasion in A549 cells. Src/epidermal growth factor receptor (EGFR) was involved in resistin-induced migration and invasion. Resistin increased the phosphorylation of EGFR through the TLR4/Src pathway. We also found that PI3K/nuclear factor (NF)-κB were the intracellular downstream effectors mediating resistin-induced migration and invasion. Taken together, our results suggested that resistin promoted lung adenocarcinoma metastasis through the TLR4/Src/EGFR/PI3K/NF-κB pathway.
Found 
Found 

Top-30

Journals

1
2
1
2

Publishers

1
2
3
4
5
6
7
8
1
2
3
4
5
6
7
8
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Share
Cite this
GOST | RIS | BibTex | MLA
Found error?